Moffitt Cancer Center is bringing the most advanced proton therapy system to the greater Tampa Bay area: The Proteus®ONE.
Proton therapy is one of the most advanced cancer treatment technologies available. While conventional radiation uses photons, proton therapy uses protons, or positively charged atomic particles. Protons can be precisely controlled to release much of their energy directly into the tumor, thereby reducing damage to nearby healthy tissue.
This transformative technology positions Moffitt at the forefront of cancer care and offers patients access to highly effective, minimally invasive treatments that produce better outcomes.
Opening Spring 2026, Moffitt's 30,000-square-foot Proton Center will begin installation in March 2025 at our SPEROS FL campus in Pasco County, Florida. The Proteus®ONE will solidify Moffitt’s Speros campus as a premier health care destination and emerging global hub for research and innovation.
Researchers at Speros will be able to explore novel proton therapy applications, including immunotherapies. IBA has also developed emerging technologies ConformalFLASH* and DynamicARC* that will be offered to patients once they receive regulatory clearance.
*ConformalFLASH® and DynamicARC® are registered brands of IBA’s Proton Therapy, which are currently under research and development.
Combined with an expert team of the world's top clinicians, therapists and physicists, proton therapy gives Moffitt patients access to highly effective treatments. With better results and the ability to treat complex or difficult-to-reach tumors, especially those located near critical organs, IBA's Proteus®ONE will help Moffitt patients return to their lives faster and with fewer treatment side effects.